• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Transitional cell carcinoma associated with aristolochic acid nephropathy: most common cancer in chronic hemodialysis patients in China

摘要Background The research of cancer in patients on hemodialysis (HD) in China has not been reported.The aim of this study was to investigate the clinical and histological features and outcomes of cancer in Chinese HD patients.Methods The study subjects were 49 cancer patients (1.4%) out of 3448 end stage renal disease (ESRD) patients maintained on HD at China-Japan Friendship Hospital from October 1997 to July 2011.Results Urinary tract cancer (74%) was the most common followed by gastrointestinal tract cancer (12%),breast cancer (6%),lung cancer (4%),thyroid cancer (2%),and hematologic cancer (2%).Thirty-three patients (67%) had urinary tract transitional cell carcinoma (TCC) and 29 of them had aristolochic acid nephropathy (AAN) as underlying disease.Death occurred in eight patients out of 49,and the survival rate of HD patients with cancer was similar to those without cancer (P=0.120).Conclusion The urinary tract TCC is the most common cancer in HD patients with AAN in one of the centers of northern China.

更多
广告
作者单位 Department of Blood Purification, China-Japan Friendship Hospital, Beijing 100029, China [1] Department of Nephrology, China-Japan Friendship Hospital, Beijing 100029, China [2] Department of Urology , China-Japan Friendship Hospital, Beijing 100029, China [3]
栏目名称 ORIGINAL ARTICLES
DOI 10.3760/cma.j.issn.0366-6999.2012.24.025
发布时间 2013-02-22
提交
  • 浏览196
  • 下载8
中华医学杂志(英文版)

中华医学杂志(英文版)

2012年125卷24期

4460-4465页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷